17/12/2024
FYI for veterinarians and pet owners: The FDA has updated the warning label for potential adverse events following "Librela" administration in dogs to include: ataxia, seizures, other neurologic signs, including but not limited to, paresis, recumbency, urinary incontinence; polyuria, and polydipsia.
https://www.fda.gov/animal-veterinary/product-safety-information/dear-veterinarian-letter-notifying-veterinarians-about-adverse-events-reported-dogs-treated-librela?fbclid=IwY2xjawHO4WpleHRuA2FlbQIxMQABHaP3Q2LnzomSYlZzWjOlIsGgT7YVayl4hFjcvje5Vrkh1PUQDmqOt0g-sg_aem_ixc65DP-A5ekGbbKFV8bUA
The FDA has identified and analyzed adverse events in dogs treated with Librela (bedinvetmab injection).